A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/1998
10/15/1998	WO1998030589A3 Secreted proteins and polynucleotides encoding them
10/15/1998	WO1998018925A3 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
10/15/1998	CA2286457A1 Estra-5(10),7-dienes with estrogenic activity
10/15/1998	CA2286454A1 Calcilytic compounds
10/15/1998	CA2286303A1 20 human secreted proteins
10/15/1998	CA2285960A1 Use of lactoferin in the treatment of allergen induced disorders
10/15/1998	CA2285679A1 Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same
10/15/1998	CA2285556A1 Calcilytic compounds
10/14/1998	EP0870825A1 Human protein kinases hYAK3
10/14/1998	EP0870761A1 Thiocolchicine derivatives with antiinflammatory and muscle relaxant activities
10/14/1998	EP0870504A2 New compositions comprising biologically active silicon
10/14/1998	EP0870033A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
10/14/1998	EP0870019A2 Cell activation process and reagents therefor
10/14/1998	EP0869974A1 Compounds with growth hormone releasing properties
10/14/1998	EP0869968A1 Growth-hormone secretagogues
10/14/1998	EP0869967A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
10/14/1998	EP0869947A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/14/1998	EP0869945A1 Catechol diethers derivatives useful as pharmaceutical agents
10/14/1998	EP0869943A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis
10/14/1998	EP0869810A1 Cyclosporin-containing soft capsule preparations
10/14/1998	EP0869805A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications
10/14/1998	EP0869787A1 Vitronectin receptor antagonists
10/14/1998	EP0630248B1 Use of estriol for the manufacture of a transdermal therapeutic system for treating climacteric osteoporosis
10/14/1998	CN1196087A Novel protein HMW human MP52
10/14/1998	CN1195529A Drug for curing traumatic injuries and its preparing method
10/13/1998	US5821253 Tetrahydrobenzo a!fluorene compounds and methods of use
10/13/1998	US5821123 Modified antibody variable domains
10/08/1998	WO1998043963A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998	WO1998043959A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
10/08/1998	WO1998043661A1 Use of substances having oxytocin activity for preparation of medicaments for wound healing
10/08/1998	WO1998043623A1 Antirheumatic agents
10/08/1998	CA2285372A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998	CA2285215A1 Antirheumatic agents
10/07/1998	EP0869178A1 SAF-3, Sialoadhesin family member-3
10/07/1998	EP0869132A1 "Steroid compounds having contraceptive and anti-osteoporosis activity"
10/07/1998	EP0868190A1 Phospholipid and propylene glycol based lubricant
10/07/1998	EP0724566B1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
10/07/1998	CN1194842A Tincture for anti-inflammation and stopping pain
10/06/1998	US5817677 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation
10/06/1998	US5817648 Vitamin D3 analogues having an unsaturated side chain
10/02/1998	CA2233787A1 Sialoadhesin family member-3
10/02/1998	CA2223021A1 Novel human neurotensin receptor type 2 and splice variants thereof
10/01/1998	WO1998042739A2 Secreted proteins and polynucleotides encoding them
10/01/1998	WO1998042738A1 87 human secreted proteins
10/01/1998	WO1998042662A1 Certain cyclic thio substituted acylaminoacid amide derivatives
10/01/1998	WO1998042366A1 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
10/01/1998	WO1998042357A1 Use of an extract of alchemilli vulgaris
10/01/1998	CA2284550A1 87 human secreted proteins
10/01/1998	CA2284548A1 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
10/01/1998	CA2283631A1 Secreted proteins and polynucleotides encoding them
09/1998
09/30/1998	EP0867508A2 Olfactory receptor of the 7-transmembrane receptor family - OLRCC15 receptor
09/30/1998	EP0866720A1 Methods of increasing lean tissue mass using ob protein compositions
09/30/1998	EP0866692A1 Use of bicyclic mono- or diketone derivatives, resulting compounds, and use thereof as a drug for treating inflammation, migraine and shock
09/30/1998	EP0866656A1 Inhibition of tumor necrosis factor alpha
09/29/1998	US5814610 Tetrapeptides to hexapeptides with specific amino acid sequences for wound healing agents and osteoblast or fibroblastic growth promoters
09/29/1998	US5814607 Pulmonary delivery of active fragments of parathyroid hormone
09/24/1998	WO1998041519A1 Novel cannabinoid receptor agonists
09/24/1998	WO1998041501A1 2-alkylidene-19-nor-vitamin d compounds
09/24/1998	WO1998041500A1 2-alkyl-19-nor-vitamin d compounds
09/24/1998	WO1998041218A1 An aqueous metal bicarbonate solution and method of use
09/24/1998	WO1998041217A1 Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration
09/24/1998	CA2283797A1 Novel cannabinoid receptor agonists
09/24/1998	CA2283691A1 Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration
09/23/1998	EP0866125A1 Novel protein hmw human mp52
09/23/1998	EP0866124A2 Composition containing a compound modifying directly or indirectly the activity of endogenous T1-M protein
09/23/1998	EP0865446A1 Agents for promoting bone formation
09/23/1998	EP0865445A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
09/23/1998	EP0865428A1 Vitamin d analogues
09/23/1998	EP0865422A1 Amino alcohol derivatives, methods of producing said derivatives and medicaments containing them
09/23/1998	CN1193915A Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
09/23/1998	CN1193623A Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
09/22/1998	US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis
09/22/1998	US5811549 Process of preparing imidazole compounds
09/22/1998	US5811535 Human cartilege gp39-like gene
09/22/1998	US5811421 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods
09/22/1998	US5811415 Lipophilic benzothiophenes
09/22/1998	US5811096 Comprises urate oxidase and poloxamer in buffered aqueous medium
09/22/1998	CA2138367C Use of phosphonates for the treatment of osteoporosis
09/22/1998	CA2138366C Methods for the treatment of arthritis using phosphonates and nsaids
09/21/1998	CA2232637A1 Composition containing a compound which directly or indirectly modifies the activity of endogenous t1-m protein
09/17/1998	WO1998040486A2 Secreted proteins and polynucleotides encoding them
09/17/1998	WO1998040482A1 Growth factor receptor binding protein
09/17/1998	WO1998040406A1 Calcium phosphopeptide complexes
09/17/1998	WO1998040404A2 Secreted proteins and polynucleotides encoding them
09/17/1998	WO1998040093A1 Method of antagonizing the human src sh2 domain
09/17/1998	WO1998040085A1 Stable solid preparation containing vitamin d3 and tricalcium phosphate
09/17/1998	WO1998040070A1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
09/17/1998	WO1998024905A3 Secreted proteins and polynucleotides encoding them
09/17/1998	DE19710054A1 Pharmazeutische Zubereitung Pharmaceutical composition
09/17/1998	CA2727634A1 Calcium fluoride phosphate complexes
09/17/1998	CA2284183A1 Stable solid preparation containing vitamin d3 and tricalcium phosphate
09/17/1998	CA2283472A1 Method of antagonizing the human src sh2 domain
09/17/1998	CA2283296A1 Growth factor receptor binding protein
09/17/1998	CA2283195A1 Secreted proteins and polynucleotides encoding them
09/17/1998	CA2283193A1 Secreted proteins and polynucleotides encoding them
09/16/1998	EP0863892A1 Lipophilic benzothiophenes
09/16/1998	EP0863881A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases
09/16/1998	EP0863757A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
09/16/1998	EP0570380B1 Novel methylenebisphosphonic acid derivatives
09/16/1998	CN1193325A Cell adhension inhibitors

1 ... 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 ... 820